VERNON W ANTHONY 4

What Happened

• Vernon W. Anthony, a director of NovoCure Ltd (NVCR), exercised stock options to acquire 21,500 ordinary shares on 2026-04-28 at an exercise price of $11.39 per share, for a total cash outlay of $244,885. The same filing also shows a simultaneous disposition/conversion of 21,500 shares at $0 (derivative).
• The transactions are reported under transaction code M (exercise/conversion of a derivative). The acquisition reflects exercising options rather than an open-market purchase; the $0 disposal indicates those shares were surrendered or withheld as part of the same transaction (e.g., to cover taxes or the exercise cost), rather than sold for cash.

Key Details

• Transaction date: 2026-04-28; Filed: 2026-04-28 (timely filing).
• Acquired: 21,500 shares at $11.39 each = $244,885 total.
• Disposed: 21,500 shares at $0.00 (derivative disposition reported in same filing).
• Shares owned after transaction: not specified in the provided filing details.
• Transaction code: M = Exercise/conversion of derivative. The filing itself does not include an explicit footnote stating the reason for the $0 disposal (commonly used for share withholding/tax/payment).

Context

• Exercising options converts the right to buy shares into actual shares; when shares are simultaneously surrendered or withheld at $0, that usually reflects a net or share-surrendered exercise (covers taxes or exercise cost) rather than a market sale. This is generally a routine, non-market transaction and not a direct buy/sell signal to the market.
• For retail investors, exercises show insiders exercising existing rights; outright purchases on the open market can be more indicative of fresh bullish conviction.